Latin American countries instituted a wide range of countermeasures when COVID was declared a global pandemic over a year ago.

The pharmaceutical sector weathered the pandemic well, as it was declared an essential activity and received a large influx of funds to combat COVID. Countries around the region have seen trends like greater government economic intervention, the rise of telemedicine, and more streamlined regulatory processes, leading to an increased dependence on the pharmaceutical industry.